| Bioactivity | Pivekimab is a human IgG1 monoclonal antibody targeting interleukin 3 (IL-3) and CD123. Pivekimab can be used in the study of blastocytic plasmacytoid dendritic cell tumor (BPDCN)[1]. |
| Name | Pivekimab |
| CAS | 2234335-84-1 |
| Appearance | Liquid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Patrick ZM, et, al. Methods of treatment using anti-CD123 immunoconjugates. WO2020092533. |